The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

VNDA FINANCIAL STATEMENTS

Vanda Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

VNDAVanda Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0200 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue215.7 M $Gross Profit106.7 M $ · 49%Operating Income-185.7 M $ · -86%Pre-tax Income-177.2 M $ · -82%Net Income to Owners-274.9 M $ · -127%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue215.7 M $+6.0%
Gross Profit106.7 M $-43.9%
Operating Income-185.7 M $—
EBITDA-169.3 M $—
Net Income to Owners-274.9 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets412.5 M
  • Equity220.2 M $53%
  • Current Liabilities164 M $40%
  • Long-term Liabilities28.3 M $7%

Key Figures

YoY change
Total Assets412.5 M $-34.0%
Total Liabilities192.3 M $+38.9%
Total Equity220.2 M $-54.7%
Cash & ST Investments170 M $-47.8%
Total Debt18.2 M $+56.4%
Net Debt-37.7 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M-50 M0-111.3 M $Operating86.5 M $Investing-1.9 M $Financing-26.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow-111.3 M $—
Capital Expenditures484 K $-56.4%
Free Cash Flow-111.7 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on VNDA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.